JPMorgan Chase & Co. cut its stake in shares of Sapiens International Co. (NASDAQ:SPNS - Free Report) by 13.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 154,213 shares of the technology company's stock after selling 23,665 shares during the period. JPMorgan Chase & Co. owned approximately 0.28% of Sapiens International worth $4,144,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the business. Zions Bancorporation N.A. lifted its position in Sapiens International by 16.9% in the 4th quarter. Zions Bancorporation N.A. now owns 67,830 shares of the technology company's stock valued at $1,823,000 after purchasing an additional 9,828 shares during the last quarter. LPL Financial LLC boosted its holdings in Sapiens International by 17.0% in the fourth quarter. LPL Financial LLC now owns 68,255 shares of the technology company's stock worth $1,742,000 after purchasing an additional 9,917 shares in the last quarter. Quantbot Technologies LP boosted its position in Sapiens International by 653.3% during the fourth quarter. Quantbot Technologies LP now owns 10,614 shares of the technology company's stock worth $285,000 after purchasing an additional 9,205 shares during the period. Royce & Associates LP boosted its holdings in shares of Sapiens International by 65.7% during the 4th quarter. Royce & Associates LP now owns 932,703 shares of the technology company's stock worth $25,062,000 after buying an additional 369,947 shares during the period. Finally, HighTower Advisors LLC grew its position in shares of Sapiens International by 28.6% in the fourth quarter. HighTower Advisors LLC now owns 8,108 shares of the technology company's stock valued at $218,000 after purchasing an additional 1,801 shares during the last quarter. Institutional investors own 30.73% of the company's stock.
Sapiens International Stock Up 1.4 %
SPNS stock traded up $0.37 during trading hours on Thursday, reaching $27.63. 23,848 shares of the stock were exchanged, compared to its average volume of 150,872. The firm's 50-day moving average is $26.96 and its 200-day moving average is $28.76. Sapiens International Co. has a 12 month low of $23.69 and a 12 month high of $41.22. The company has a market cap of $1.54 billion, a price-to-earnings ratio of 21.42 and a beta of 1.10. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.24 and a quick ratio of 2.18.
Sapiens International (NASDAQ:SPNS - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The technology company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.01). The business had revenue of $134.31 million during the quarter, compared to analyst estimates of $135.89 million. Sapiens International had a net margin of 13.31% and a return on equity of 17.42%. On average, equities research analysts expect that Sapiens International Co. will post 1.42 earnings per share for the current year.
Sapiens International Increases Dividend
The company also recently disclosed a semi-annual dividend, which was paid on Wednesday, April 16th. Shareholders of record on Monday, April 7th were paid a dividend of $0.66 per share. This represents a yield of 2.2%. This is an increase from Sapiens International's previous semi-annual dividend of $0.22. The ex-dividend date was Monday, April 7th. Sapiens International's dividend payout ratio is presently 46.51%.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the stock. Barclays lowered their price objective on shares of Sapiens International from $30.00 to $28.00 and set an "underweight" rating on the stock in a research note on Wednesday, February 19th. Jefferies Financial Group lowered shares of Sapiens International from a "buy" rating to a "hold" rating and cut their price objective for the company from $36.00 to $28.00 in a research report on Monday, February 3rd. Finally, Needham & Company LLC restated a "buy" rating and set a $35.00 price target on shares of Sapiens International in a research note on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Sapiens International presently has a consensus rating of "Hold" and a consensus price target of $33.50.
Check Out Our Latest Report on Sapiens International
Sapiens International Profile
(
Free Report)
Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.
Further Reading
Before you consider Sapiens International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sapiens International wasn't on the list.
While Sapiens International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
